8-K: Edgemode Secures $50M Equity Line, $250K Debt; CTO Resigns
Capital Raising and Management Change
Edgemode, Inc. announced a $50 million equity line of credit and a $250,000 convertible promissory note facility with ClearThink Capital Partners, alongside the resignation of its Chief Technology Officer.
Summary
- Entered into a Securities Purchase Agreement (Promissory Note Purchase Agreement) with ClearThink Capital Partners, LLC on September 2, 2025, effective August 20, 2025.
- Sold an unsecured original issue discount promissory note (First Promissory Note) with a principal amount of $172,500 for net proceeds of $150,000.
- Will sell a second unsecured original discount promissory note (Second Promissory Note) with a principal amount of $115,000 for net proceeds of $100,000, effective five days after the ELOC Registration Statement filing.
- The Promissory Notes carry a 12% interest rate, which is applied to the principal on the issuance date and is payable on the maturity date of August 31, 2026.
- Promissory Notes are convertible into common stock at a fixed price of $0.01 per share, with potential downward adjustments to $0.0075 or the lowest traded price if the stock trades below these thresholds for more than 5 consecutive days.
- Conversion of Promissory Notes is limited to 9.99% beneficial ownership for the investor and its affiliates.
- Entered into an Equity Line of Credit (ELOC) Agreement with ClearThink Capital Partners, LLC on September 4, 2025, for up to $50,000,000 of common stock (Purchase Shares).
- Issued 25,000,000 restricted shares of common stock as commitment shares to the investor in connection with the ELOC Agreement.
- Entered into a Registration Rights Agreement on September 4, 2025, obligating the company to file an S-1 Registration Statement for the resale of Purchase Shares within 45 days and use best efforts for effectiveness.
- Issued 7,500,000 shares of restricted common stock to a consultant on September 4, 2025, pursuant to an amendment to a services agreement.
- Dr. Niclas Adler resigned as Chief Technology Officer and as a member of the Board of Directors, effective September 1, 2025.
Sentiment
Score: 3
Explanation: The company secured significant financing, which is positive for liquidity, but the terms are highly dilutive and unfavorable for existing shareholders, coupled with management changes and internal control weaknesses, indicating substantial risks and potential distress.
Positives
- Secured access to significant potential capital of up to $50,000,000 through an Equity Line of Credit, providing a flexible financing option.
- Obtained immediate working capital of $150,000 from the first promissory note, with an additional $100,000 expected from the second note, addressing short-term liquidity needs.
- The Registration Rights Agreement facilitates the resale of shares by the investor, which is essential for the effective utilization of the Equity Line of Credit.
Negatives
- The convertible promissory notes carry a high interest rate of 12% and significant original issue discounts, resulting in $250,000 net proceeds for $287,500 in principal.
- The conversion price for the promissory notes can reset downwards to as low as the lowest traded price during a default period, leading to substantial dilution for existing shareholders if the stock price declines.
- The issuance of 25,000,000 restricted commitment shares to the investor and 7,500,000 restricted shares to a consultant represents immediate and significant dilution for existing shareholders.
- The Equity Line of Credit purchase price is set at a discount (70-85%) to the average of the two lowest daily closing prices during a valuation period, which can lead to further dilution.
- The company disclosed 'weakness in internal controls and that the Company’s disclosure controls and procedures are not effective,' indicating significant operational and governance issues.
- The resignation of Dr. Niclas Adler as Chief Technology Officer and Board member could signal a loss of key expertise or strategic direction.
Risks
- Significant shareholder dilution from the conversion of promissory notes and the issuance of shares under the Equity Line of Credit, especially with potential downward adjustments to conversion prices.
- Risk of stock price volatility and further declines due to the dilutive nature of the financing agreements and the company's status as a 'former shell company.'
- Potential for the company to become delinquent in SEC filings or lose its listing on OTC Markets, which are events of default under the promissory notes and could trigger acceleration of debt.
- Operational risks associated with 'weakness in internal controls and ineffective disclosure controls and procedures,' which can lead to financial misstatements or regulatory non-compliance.
- Loss of key management and board expertise with the resignation of the CTO and board member, potentially impacting strategic execution and innovation.
- The Equity Line of Credit agreement has conditions precedent that could prevent the company from drawing on the full commitment amount, such as registration statement effectiveness lapsing or trading suspension.
Future Outlook
The company plans to use the net proceeds from the promissory notes for working capital. It is obligated to file an S-1 Registration Statement within 45 days to register the resale of shares under the Equity Line of Credit and use best efforts to have it declared effective. The ELOC provides a mechanism for future capital raises, subject to market conditions and company performance, with a potential maturity date for the facility approximately 24 months after its commencement.
Management Comments
- Proceeds from the sale of the Promissory Notes will be used for working capital.
- Dr. Adler's resignation did not involve any disagreement with the Board, the Company, or its management on any matter relating to the company's operations, policies, or practices.
Industry Context
The use of an Equity Line of Credit and convertible debt is common for smaller, growth-stage companies or those with limited access to traditional financing, often indicating a need for flexible capital. The terms, particularly the variable conversion price and significant discounts, are typical of such arrangements but can be highly dilutive. The resignation of a Chief Technology Officer can be a concern for technology-focused companies, potentially impacting innovation or strategic direction, especially if a replacement is not immediately announced.
Comparison to Industry Standards
- The 12% interest rate on the promissory notes, combined with original issue discounts, is relatively high, reflecting the perceived risk associated with the company, particularly for a 'former shell company.'
- The conversion price reset mechanism (down to $0.0075 or lowest traded price) is aggressive and highly dilutive, more typical of distressed or micro-cap companies seeking capital of last resort, rather than established industry players.
- The 70-85% discount to market price for ELOC purchases is also on the higher end of typical equity line discounts, further indicating the company's need for capital and potentially limited financing options.
- The issuance of 25,000,000 commitment shares for a $50 million ELOC is a substantial upfront cost, representing immediate dilution for existing shareholders, which is a significant percentage of the total facility.
- The disclosure of 'weakness in internal controls and that the Company’s disclosure controls and procedures are not effective' is a significant red flag, contrasting sharply with the robust governance standards expected of mature public companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Technology Officer and Board Member | Dr. Niclas Adler | N/A | 2025-09-01 | Resignation; did not involve any disagreement with the Board, the Company, or management on any matter relating to operations, policies, or practices. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Controls Disclosure | Company disclosed 'weakness in internal controls and that the Company’s disclosure controls and procedures are not effective.' | N/A | Indicates significant deficiencies in financial reporting and operational oversight, potentially increasing risk for investors and requiring substantial remediation efforts. |
Stakeholder Impact
- Shareholders: Significant potential for dilution due to the convertible promissory notes with variable conversion prices and the Equity Line of Credit, which allows for sales at a discount to market. The issuance of 25,000,000 commitment shares and 7,500,000 consultant shares also immediately dilutes existing holdings.
- Creditors: The promissory notes provide a source of capital, but the company's financial health and ability to repay debt are subject to the success of its operations and the effectiveness of its internal controls.
- Management/Employees: The resignation of the CTO could impact morale and strategic direction, but the new capital provides resources for operations.
Next Steps
- File an S-1 Registration Statement within 45 days of September 4, 2025, to register the resale of Purchase Shares under the ELOC.
- Use best efforts to have the S-1 Registration Statement declared effective by the SEC at the earliest possible date.
- Receive an additional $100,000 in net proceeds from the Second Promissory Note five days after the ELOC Registration Statement filing.
- Maintain listing on OTC Markets and comply with reporting requirements to avoid events of default.
- Address 'weakness in internal controls and ineffective disclosure controls and procedures.'
Key Dates
| Date | Description |
|---|---|
| 2025-08-20 | Effective date of the First Promissory Note. |
| 2025-09-01 | Effective date of Dr. Niclas Adler's resignation as Chief Technology Officer and Board member. |
| 2025-09-02 | Date of entry into the Promissory Note Purchase Agreement. |
| 2025-09-04 | Date of entry into the Equity Line of Credit Agreement and Registration Rights Agreement. |
| 2025-10-19 | Deadline for filing the S-1 Registration Statement (45 days from September 4, 2025). |
| 2025-12-31 | Termination option date for ELOC if Commencement conditions are not met. |
| 2026-08-31 | Maturity Date for the Promissory Notes. |
Recommendation
strong sellThe financing terms are highly dilutive and predatory, indicating the company is likely in a distressed financial position. The variable conversion price, deep discounts, and substantial commitment shares will significantly erode shareholder value. Coupled with the disclosed 'weakness in internal controls' and the resignation of a key executive, the company faces severe operational and governance challenges. These factors suggest a high probability of further share price decline and substantial risk for investors.
Keywords
Edgemode, EDGM, ClearThink Capital Partners, Equity Line of Credit, ELOC, Convertible Promissory Note, Dilution, SEC Filing, 8-K, Capital Raise, Registration Rights, Management Change, CTO Resignation, Working Capital, OTC Markets
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.